Purinergic-receptor oligomerization: implications for neural functions in the central nervous system. 2004

Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
Department of Molecular Cell Signaling, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo, 183-8526, Japan. nakata@tmin.ac.jp

It is becoming clear that the functions of G protein-coupled receptors (GPCRs), the largest family of plasma membrane-localized receptors, are regulated by direct oligomeric formation between GPCRs, as either homo- or hetero-oligomers. This review article explores the mechanistic implications of GPCR dimerization, especially among purinergic receptors, adenosine receptors and P2 receptors, which play critical roles in the regulation of neurotransmission in the central nervous system. Briefly, adenosine receptors are able to form a heteromeric complex with P2 receptors that generates an adenosine receptor with P2 receptor-like agonistic pharmacology. This mechanism may be used to fine-tune purinergic inhibition locally at sites where there is a particular oligomerization structure between purinergic receptors, and to explain the undefined adenosine-like purinergic functions of adenine nucleotides. Purinergic receptors also form oligomers with GPCRs of other families present in the brain, such as dopamine receptors and metabotropic glutamate receptors, to alter the functional properties. The effect of GPCR oligomerization on receptor functions is thus considered as an important system in the central nervous system.

UI MeSH Term Description Entries
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D011983 Receptors, Purinergic Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP. Methyladenine Receptors,Purine Receptors,Purinergic Receptor,Purinergic Receptors,Purinoceptors,Purine Receptor,Purinoceptor,Receptors, Methyladenine,Receptors, Purine,Receptor, Purine,Receptor, Purinergic
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
January 2018, Journal of biological regulators and homeostatic agents,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
August 2006, Pflugers Archiv : European journal of physiology,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
February 2009, Trends in neurosciences,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
February 2017, Current opinion in pharmacology,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
July 2008, Nature reviews. Drug discovery,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
November 1995, Pharmacology & toxicology,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
October 2020, Brain, behavior, and immunity,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
June 2007, International journal of radiation oncology, biology, physics,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
May 2008, Molecular and cellular endocrinology,
Hiruyasu Nakata, and Kazuaki Yoshioka, and Toshio Kamiya
November 2020, Neuroscience bulletin,
Copied contents to your clipboard!